Joanne Chou, MPH

Research Biostatistician II

Joanne Chou, MPH

Office Phone



Columbia University

Current Research Interests

Ms. Chou’s main collaborations have been with pediatric, colorectal surgery service and epidemiology.

Ms. Chou has worked on several survivorship studies with Dr. Moskowitz, Dr. Ford from consulting service, and Dr. Oeffinger from the department of pediatric to better understand long-term health issues related to cancer therapy among patients surviving childhood cancer. In the clinical setting, she has worked closely with Dr. Gonen and Dr. Weiser from the colorectal service to develop nomogram to predict recurrence in colon cancer. In addition, they have also developed a nomogram to predict overall survival in colon cancer using SEER public data. In Epidemiology study, she has worked with Dr. Engel in the Epidemiology Service to examine association between risk of melanoma and exposure of PCBs, and organochlorine pesticides using a nested case-control design in a large population cohort. She has also collaborated with Dr. Orlow to examine the association with clinical factors and several gene polymorphisms in melanoma patients. Finally, she has recently begun to work on a colorectal cancer prevention project with Dr. Zauber, involving the adenoma prevention with Celecoxib (APC) Placebo-controlled trial to determine the association between the level of red blood cell folate and the risk of adenoma recurrence.

Ms. Chou’s research interests include methods of survival analysis in particular with nomogram construction and validation.


Selected Publications

  1. Oeffinger KC, Ford JS, Moskowitz CS, Diller LR, Hudson MM, Chou JF, Smith SM, Mertens AC, Henderson TO, Friedman DL, Leisenring WM, Robison LL. Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. JAMA. 2009 Jan 28;301(4):404-14.PMID: 19176442 [PubMed - indexed for MEDLINE]
  2. Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Saltz LB, Goodman KA, Minsky BD, Wong WD, Weiser MR. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer. 2008 Jul 1;113(1):57-64.PMID: 18442099 [PubMed - indexed for MEDLINE]
  3. Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Landmann RG, Guillem JG, Paty PB, Temple LK, Wong WD, Weiser MR. Identification of patients with high-risk stage II colon cancer for adjuvant therapy. Dis Colon Rectum. 2008 May;51(5):503-7. Epub 2008 Mar 6.PMID: 18322753 [PubMed - indexed for MEDLINE]
  4. Weiser MR, Landmann RG, Kattan MW, Gonen M, Shia J, Chou J, Paty PB, Guillem JG, Temple LK, Schrag D, Saltz LB, Wong WD. Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol. 2008 Jan 20;26(3):380-5.PMID: 18202413 [PubMed - indexed for MEDLINE]